Skip to main content
OpenTrials
Completed

NCT Number: NCT01707576

Screening of Adolescent Mental Suffering

The primary purpose is to estimate the prevalence of depression and subsyndromal states among adolescents 13 to 17 years consulting to hospital emergency rooms for any reason, for they are another way of tracking this suffering, as they host many troubled teens at once for health problems and accidents sometimes iterative, reflecting their risk behaviour.

Secondary purposes are to assess the feasibility and desirability of a post-emergency medical consultation for adolescents who scored high on a self-administered questionnaire, and to assess the impact of this approach by later monitoring.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of paediatric emergencies, Ambroise Paré universitary hospital

Boulogne-Billancourt, Île-de-France Region, 92100, France

About this study

This is a multicenter longitudinal survey in three emergency centers in Ile-de-France, with 2 periods of daily collection and comprehensive three weeks spread over one year, followed by a remote evaluation.

The project is as follows:

Phase A :

  • Evaluation of the prevalence: systematic execution of self-administered questionnaire by all adolescents consulting, night and day in each center.

Phase B :

  • For adolescents whose outcome questionnaire exceed 4, a post-emergency consultation will be proposed within 15 days.
  • Telephone survey, 12 months after the passage of emergency every teenager who completed self-administered questionnaire and presenting himself to the post-emergency consultation. This survey will aim to assess the psychological status of adolescents and the impact of any specific treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adolescents over the age of 13 to 17 years when passing emergency whatever the reason for consultation (surgical or medical, including attempted suicide or psychological problem)

Exclusion criteria

  • Young people not reading French.

Treatment and study plan

consultation 10 days later

Behavioral

new depression screening

Primary outcomes

  1. Responses to Self-reported questionnaire on risk behaviors, somatic complaints by adolescents and parents

    Time frame: 10 months

    A self-questionnaire ADRS (Adolescent Depression Rating Scale) will be asked to all adolescents to complete. Also the other questions will be answered by them concenrning somatisations and risk behaviors. Parents respond in the same time a self questionnaire.

Secondary outcomes

  1. Post-emergency consultation and reassessment of hetero-ADRS clinician questionnaire

    Time frame: 6 months

    Actual presence of adolescents suspected of depression at the post-emergency consultation and reassessment of their state using the hetero-ADRS-clinician questionnaire.

Other outcomes

  1. Revaluation after one year

    Time frame: 6 months

    Revaluation after 1 year of the teenagers who come back to visit.

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • Fondation de France
  • Pfizer

Registry information

Official study title

SCREENING OF ADOLESCENT MENTAL SUFFERING CONSULTANT TO EMERGENCIES, MANAGEMENT AND Later MONITORING

Acronym: DESPERADOS

Important dates

Study start
2010
Primary completion
2011
Study completion
2012
First posted
Oct 16, 2012
Registry last updated
Apr 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.